Clariscan
Drug
GE HealthCare
Total Payments
$20,636
Transactions
8
Doctors
5
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $12,780 | 1 | 1 |
| 2023 | $7,813 | 4 | 1 |
| 2022 | $43.22 | 3 | 3 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $12,780 | 1 | 61.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,813 | 4 | 37.9% |
| Food and Beverage | $43.22 | 3 | 0.2% |
Top Doctors Receiving Payments for Clariscan
Ad
Manufacturing Companies
- GE HEALTHCARE $20,593
- GE HealthCare $43.22
Product Information
- Type Drug
- Total Payments $20,636
- Total Doctors 5
- Transactions 8
About Clariscan
Clariscan is a drug associated with $20,636 in payments to 5 healthcare providers, recorded across 8 transactions in the CMS Open Payments database. The primary manufacturer is GE HealthCare.
Payment data is available from 2022 to 2024. In 2024, $12,780 was paid across 1 transactions to 1 doctors.
The most common payment nature for Clariscan is "Consulting Fee" ($12,780, 61.9% of total).